Biodistribution and Clearance of Small Molecule Hapten Chelates for Pretargeted Radioimmunotherapy

Evaluation of Bifunctional Chelates for the Development of Gallium-Based Radiopharmaceuticals

(2010) Cara L. Ferreira et al.   BIOCONJUGATE CHEMISTRY

A comparative analysis of conventional and pretargeted radioimmunotherapy of B-cell lymphomas by targeting CD20, CD22, and HLA-DR singly and in combinations

(2009) J. M. Pagel et al.   BLOOD

Pretargeted Versus Directly Targeted Radioimmunotherapy Combined with Anti-CD20 Antibody Consolidation Therapy of Non-Hodgkin Lymphoma

(2009) R. M. Sharkey et al.   JOURNAL OF NUCLEAR MEDICINE

MIRD Dose Estimate Report No. 20: Radiation Absorbed-Dose Estimates for 111In- and 90Y-Ibritumomab Tiuxetan

(2009) D. R. Fisher et al.   JOURNAL OF NUCLEAR MEDICINE

177Lu- labeled MOv18 as compared to 131I- or 90Y-labeled MOv18 has the better therapeutic effect in eradication of alpha folate receptor-expressing tumor xenografts

(2009) Alberto Zacchetti et al.   NUCLEAR MEDICINE AND BIOLOGY

A modular IgG-scFv bispecific antibody topology

(2009) Kelly Davis Orcutt et al.   PROTEIN ENGINEERING DESIGN & SELECTION

Synthesis and Evaluation of Technetium-99m- and Rhenium-Labeled Inhibitors of the Prostate-Specific Membrane Antigen (PSMA)

(2008) Sangeeta R. Banerjee et al.   JOURNAL OF MEDICINAL CHEMISTRY